Pharma Companies Turn to AI to Speed Up Drug Development, But Hit Hurdles
Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...
ANI Pharmaceuticals: More Than Just A Generics Company
ANI Pharmaceuticals offers an asymmetric opportunity in small-cap pharma, with a niche in generics, rare disease treatments, ...
Avadel Pharmaceuticals: Moving To A Speculative Buy
Avadel Pharmaceuticals' stock is undervalued due to peak sales potential, along with the possibility of a buyout. Click here ...
Universe Pharmaceuticals proposes revised share consolidation
Universe Pharmaceuticals INC (NASDAQ:UPC), a pharmaceutical company trading at $0.19 per share, announced today a change in its proposed share consolidation ratio. The company's stock has experienced ...
How many members of Congress receive money from pharmaceutical company PACs?
Top Republican recipients of contributions from employees or PACS associated with the pharmaceutical/health products ...
Pharma company to close Plymouth facility, lay off 58 workers
The company, which was bought by Taiwan-based Bora Pharmaceuticals in a $210 million deal last year, is keeping its facility ...
Pharma Companies Wrongly Denied Pause in Opioid Liability Suit
A district court improperly mailed remand orders to a state court after some of the defendants, including Express Scripts, challenged a ruling, requiring the suit to be stayed, a split federal appeals ...
Sonoma Pharmaceuticals (SNOA) to Release Earnings on Thursday
Sonoma Pharmaceuticals (NASDAQ:SNOA – Get Free Report) will likely be posting its quarterly earnings results before the ...
Supply Chain1d
U.S. Pharma Companies Weigh a Shift to North America — and Possibly the U.S. — for Drug Production
“Companies are realizing that investing stateside can provide more control and resilience to the drug supply chain,” says Dymowski. She cites political tensions, import and export disruptions, and ...